Florian Brand
Algemeen Directeur bij ATAI LIFE SCIENCES N.V.
Vermogen: 519 717 $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Florian Brand
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 50 | |
ATAI Life Sciences AG
 ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
DemeRx, Inc.
 DemeRx, Inc. BiotechnologyHealth Technology DemeRx, Inc. provides biotechnology services. It focuses on drug addiction among patients coping with chronic pain. The company was founded by Deborah C. Mash on March 1, 2010 and is headquartered in Miami, FL.
9
| Holding Company | Biotechnology | 9 |
COMPASS Pathfinder Holdings Ltd.
 COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017.
7
| Subsidiary | Financial Conglomerates | 7 |
Innoplexus AG
 Innoplexus AG Miscellaneous Commercial ServicesCommercial Services Innoplexus AG provides consulting-led technology and product development services. It offers innovation management, bigdata and analytics, data virtualization, cloud computing, machine learning, network analysis and text analytics services. The company was founded by Gunjan Bhardwaj and Gaurav Tripathi in 2011 and is headquartered in Stuttgart, Germany.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Perception Neuroscience, Inc.
 Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY.
6
| Subsidiary | Medical/Nursing Services | 6 |
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
| Public Company | Biotechnology | 4 | |
Recognify Life Sciences, Inc.
 Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
EntheogeniX Biosciences, Inc.
 EntheogeniX Biosciences, Inc. BiotechnologyHealth Technology EntheogeniX Biosciences, Inc. is a biotech company located in Wilmington, DE. EntheogeniX Biosciences is dedicated to advancing psychedelic research for the development of better medicines for mental health diseases such as depression, bipolar disorder, and schizophrenia. The joint venture company aims to innovate the mental healthcare system by harnessing the power of artificial intelligence and computational biophysics, along with a data-driven pipeline, to uncover new medicines from desired psychedelics to further help patients. EntheogeniX Biosciences is a partnership between atai life sciences and Cyclica. The company was founded by Naheed Kurji and is currently led by CEO Srinivas G. Rao since 2019.
2
| Joint Venture | Biotechnology | 2 |
Viridia Life Sciences, Inc.
 Viridia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of ATAI Life Sciences NV, Viridia Life Sciences, Inc. develops drug products. The company is based in Wilmington, DE. The company was founded by Florian Brand. The CEO is Glenn Short.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Florian Brand via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
Apeiron Investment Group Ltd. /Private Equity/
 Apeiron Investment Group Ltd. /Private Equity/ Investment ManagersFinance Apeiron Partners (Apeiron Partners) is a private equity/venture capital subsidiary of Apeiron Investment Group Ltd founded in 2012 by Nick Nigam. The firm is headquartered in Sliema, Malta. | Investment Managers | Founder Private Equity Investor Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Public Communications Contact | |
| BIOASIS TECHNOLOGIES INC. | Biotechnology | Director/Board Member Director/Board Member | |
| London School of Hygiene & Tropical Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Doctorate Degree Undergraduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Elevat3 Capital Ltd.
 Elevat3 Capital Ltd. Investment ManagersFinance Elevat3 Capital Ltd (Elevat3) is a venture capital firm, a subsidiary of Apeiron Investment Group Ltd. founded in 2020 by Christian Angermayer, Marlon Braumann and Thomas Hanke. The firm is headquartered in London, United Kingdom. | Investment Managers | Founder Founder | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
| Escp Business School | College/University | Graduate Degree Graduate Degree | |
| City University of New York | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of Denver | College/University | Graduate Degree Undergraduate Degree | |
Springlane GmbH
 Springlane GmbH Catalog/Specialty DistributionRetail Trade Springlane GmbH develops and operates an online food and kitchenware shopping portal. It provides users with a web-based platform for searching and buying cooking equipment and kitchen accessories, such as cooking pots and pans, electronic grills, rice cookers, glassware, plates and cups, utensils, and table decoration. It also offers a selection of wine and gourmet food products. The company was founded by Lars Christian Wilde, Marius Till Fritzsche, Alexander Luik, Nils Wilde, and Björn Rust in 2012 and is headquartered in Dusseldorf, Germany. | Catalog/Specialty Distribution | Chief Executive Officer Chairman | |
| DTHERA SCIENCES | Packaged Software | Director/Board Member Founder | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Undergraduate Degree | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| WHU-Otto Beisheim School of Management | College/University | Undergraduate Degree Undergraduate Degree | |
Compass Pathfinder Ltd.
 Compass Pathfinder Ltd. BiotechnologyHealth Technology Part of Compass Pathways Plc, COMPASS Pathfinder Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Altrincham, UK. | Biotechnology | Director/Board Member Director/Board Member | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| State University of New York at Albany | College/University | Doctorate Degree Undergraduate Degree | |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
IntroSpect Digital Therapeutics, Inc.
 IntroSpect Digital Therapeutics, Inc. BiotechnologyHealth Technology IntroSpect Digital Therapeutics, Inc. provides digital therapeutic platform for mental health care and support. The firm is designed to extend the life changing potential of psychedelics-assisted psychotherapy to patients in a scalable way. The company was founded by David Keene, Srinivas G. Rao and Florian Brand and is headquartered in San Diego, CA. | Biotechnology | Founder Chief Executive Officer | |
| BIONOMICS LIMITED | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
| Colorado State University | College/University | Undergraduate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Undergraduate Degree | |
| CANACCORD GENUITY GROUP INC. | Investment Banks/Brokers | Corporate Officer/Principal Director/Board Member | |
| HELIAD AG | Investment Managers | Director/Board Member Corporate Officer/Principal | |
Ryse Asset Management LLP
 Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management LLP (RYSE) is a venture capital firm founded in 2010 by Atique Mirza. The firm is headquartered in London, the United Kingdom. | Investment Managers | Chairman | |
Perspectum Ltd.
 Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | Medical/Nursing Services | Director/Board Member | |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member | |
| XENOPORT, INC. | Pharmaceuticals: Major | General Counsel | |
Perspectum Group Ltd.
 Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Director/Board Member | |
PlaqueTec Ltd.
 PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
| SKYE BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 28 |
| Verenigd Koninkrijk | 10 |
| Canada | 6 |
| Duitsland | 5 |
| Malta | 3 |
Sectoraal
| Consumer Services | 20 |
| Health Technology | 19 |
| Finance | 6 |
| Commercial Services | 5 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 301 |
| Corporate Officer/Principal | 145 |
| Chief Executive Officer | 65 |
| Undergraduate Degree | 62 |
| Independent Dir/Board Member | 61 |
Sterkste connecties
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Christian Angermayer | 45 |
| Wayne Riley | 34 |
| Michael Auerbach | 31 |
| Richard Serbin | 31 |
| John Thomas | 30 |
| Gregory Weaver | 22 |
| Srinivas Rao | 22 |
| Linda McGoldrick | 21 |
| Atul Pande | 20 |
| David Norton | 18 |
| Kristen MacFarlane | 18 |
| Sabrina Johnson | 17 |
| Mario David Saltarelli | 17 |
| Hans H. Hertell | 16 |
- Beurs
- Insiders
- Florian Brand
- Bedrijfsconnecties
